SENSIUMVITALS
LIVE

Serial Number

86069105

Owner

TOUMAZ HEALTHCARE LIMITED

Attorney

Mainak H. Mehta

Filing Date

Sep 19, 2013

Add to watchlist:

No watchlists yet
View on USPTO

SENSIUMVITALS Trademark

Serial Number: 86069105 • Registration: 4906912

SENSIUMVITALS is a trademark filed by TOUMAZ HEALTHCARE LIMITED on September 19, 2013. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

TOUMAZ HEALTHCARE LIMITED (9 trademarks)

C/O FRONTIER SILICON, 137 EUSTON ROAD
LONDON NW1 2AA , GB

Entity Type: 99

SENSIUM HEALTHCARE LIMITED (12 trademarks)

C/O FRONTIER SILICON, 137 EUSTON ROAD
LONDON NW12AA , GB

Entity Type: 99

Trademark Details

Filing Date

September 19, 2013

Registration Date

March 1, 2016

Published for Opposition

April 7, 2015

Goods & Services

Computer hardware and software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; computer software for controlling and managing patient medical information; computer hardware for receiving and processing apparatus for data, sound, images, information and signals, namely, computer hardware and specialized adhesive bandages, plasters and patches comprised of small sensors, thin batteries and antennas sold as unit; wireless communication devices, namely, computers, antennas, hubs, routers, personal digital assistants (PDAs), smartphones, mobile telephones, modems, communications hubs; radio converters; electronic communication devices and apparatus; visual display apparatus, namely, LCD screens, plasma display panels for medical images, electronic image display screens, electronic display interfaces, flat panel display screens, display monitors, mobile data units and terminals; computer units and terminals; electronic display screens, namely, liquid crystal displays, light emitting diode displays, plasma displays, and electrophoretic and flat panel displays; structural parts and fittings for all the aforesaid goods; computer software for wireless communication and provision, acquisition, management, monitoring, analysis, storage, recording, processing, communication, transmission, provision, collection, presentation and broadcasting of data, vital signs, medical, physiological and bio-chemical information; electronic apparatus, namely, stand-alone displays for medical images

Consultancy services relative to the physical storage of electronically-stored medical, physiological and bio-chemical information and data; physical storage of electronically-stored data or documents, namely, medical, physiological and bio-chemical information and data

Collection and management of data in the nature of data compilation and database management; data processing services in the field of healthcare; business consultancy services relating to the data processing in the field of medical, physiological, and bio-chemical health, information and data; computer file management, namely, management and compilation of computerized databases

Collection, preparation, composition, acquisition, and provision of medical, physiological, and bio-chemical information and data for treatment and diagnostic purposes; consultancy services relating to the collection, preparation, composition, storage, processing, acquisition, analysis, and management of medical, physiological, and bio-chemical information and data for treatment and diagnostic purposes

Medical diagnostic and sensing devices and apparatus, namely, sensors that can be attached to the body with a sticking plaster, bandage or adhesive patch to enable non-intrusive, continuous monitoring, broadcasting, communication and analysis of an individual's temperature, blood glucose levels, physical activity, oxygen levels, and other vital signs; medical devices, apparatus and instruments incorporating wireless communication devices and sensors, biosensors, chemical sensors and optical sensors, namely, wireless communication sensors, biosensors, chemical sensors, and optical sensors that utilize body wearable bandages, plasters and adhesive patches for use in the remote monitoring of an individual's temperature, blood glucose levels, physical activity, oxygen levels, and other vital signs and physiological information; medical products, namely, body wearable and implantable sensors and antennas for monitoring, recording, broadcasting and transmitting vital signs and other medical and physiological information, and body wearable and implantable sensors for sensing, monitoring, recording and transmitting of analog, radio frequency (RF), and global positioning satellite (GPS) signals and information concerning physiological parameters of the body, comprised of small sensors, thin batteries, and antennas; medical devices, namely, adhesive bandages, plasters and patches comprised of small sensors, thin batteries and antennas for use in the remote monitoring of an individual's temperature, blood glucose levels, physical activity, oxygen levels, and other vital signs and physiological information; electrical and electronic biosensors, chemical sensors, electrical and optical sensors for use in wireless patient body monitoring; medical devices, namely, body wearable and/or implantable sensors that interface with display and notification devices, pagers, tablet computers, mobile telephones, personal digital assistants (PDAs) and computers for use in continuous vital sign, bio-chemical and physiological monitoring and receiving and processing apparatus therefor, namely, base stations and mobile computing and operating platforms consisting of data transceivers, wireless networks and gateways for collection and management of physiological and medical data; computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual, namely, liquid crystal display (LCD) screens, plasma display panels, electronic image display screens, electronic display interfaces, flat panel display screens; computer hardware and software, specifically adapted for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data

Design and development of sensing, monitoring, recording and transmission of signals and provision of information related thereto and design and development of data receiving and processing apparatus, wireless communication devices, biosensors, chemical sensors, electrical and optical sensors; research and consultancy services relating to all the aforesaid; technical support services, namely, troubleshooting of computer software problems, diagnosing problems with medical equipment and remote administration and management of in-house and hosted datacentre devices, databases and software applications; scientific analysis of data derived from sensors, biosensors, chemical and optical sensors and information, advisory information and consultancy services relating to scientific analysis of data derived from sensors, biosensors, chemical and optical sensors; biomedical research services, namely, collection, preparation, composition, acquisition, and provision of medical, physiological, and bio-chemical information and data for scientific research purposes; consultancy services relating to the collection, preparation, composition, acquisition, analysis and management of medical, physiological, and bio-chemical information and data for scientific research purposes; electronic data storage, namely, medical, physiological and bio-chemical information and data; computer services, namely, remote management of compilation of computerized databases of others; computer software consultancy, namely consultancy relative to the electronic storage of medical, physiological, and bio-chemical information and data

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 2, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 13, 2022 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 13, 2022 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 30, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 26, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 1, 2021 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 1, 2016 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jan 26, 2016 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 16, 2016 AITU
NOTICE OF ALLOWANCE CANCELLED
Nov 30, 2015 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Nov 30, 2015 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 2, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2015 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 3, 2015 PREV
ASSIGNED TO LIE
Mar 3, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 12, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 12, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 12, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 12, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2014 GNRN
NON-FINAL ACTION E-MAILED
Aug 11, 2014 GNRT
NON-FINAL ACTION WRITTEN
Aug 11, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2014 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 25, 2014 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 21, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 21, 2014 GNSL
SUSPENSION LETTER WRITTEN
Jul 21, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2014 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 9, 2014 ASGN
NOTIFICATION OF PRIORITY ACTION E-MAILED
Dec 31, 2013 GPRN
PRIORITY ACTION E-MAILED
Dec 31, 2013 GPRA
PRIORITY ACTION WRITTEN
Dec 31, 2013 CPRA
ASSIGNED TO EXAMINER
Dec 30, 2013 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Sep 27, 2013 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2013 NWOS
NEW APPLICATION ENTERED
Sep 23, 2013 NWAP